Matches in Nanopublications for { ?s ?p "[TNF-A -863 AA genotype was associated with enhanced IBD susceptibility (odds ratio (OR), 4.82; 95% confidence interval (CI), 2.60-8.96), more so for UC (OR, 5.79; 95% CI, 2.99-11.21), Crohn's disease [CD] (OR, 3.13; 95% CI, 1.16-8.47).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP212782.RAuw5hI-I7IhmssvSnMNeNWabZRXPB0kZeE55RLflJSA8130_assertion description "[TNF-A -863 AA genotype was associated with enhanced IBD susceptibility (odds ratio (OR), 4.82; 95% confidence interval (CI), 2.60-8.96), more so for UC (OR, 5.79; 95% CI, 2.99-11.21), Crohn's disease [CD] (OR, 3.13; 95% CI, 1.16-8.47).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP212782.RAuw5hI-I7IhmssvSnMNeNWabZRXPB0kZeE55RLflJSA8130_provenance.
- NP866559.RAB30PtAf35EejGXAn0QhKogf3dq-TjwMhOahBcCLdJZY130_assertion description "[TNF-A -863 AA genotype was associated with enhanced IBD susceptibility (odds ratio (OR), 4.82; 95% confidence interval (CI), 2.60-8.96), more so for UC (OR, 5.79; 95% CI, 2.99-11.21), Crohn's disease [CD] (OR, 3.13; 95% CI, 1.16-8.47).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP866559.RAB30PtAf35EejGXAn0QhKogf3dq-TjwMhOahBcCLdJZY130_provenance.
- NP884827.RAaLAWI55TbwJ8nHGKhZzvA2-aG8VZjDlW43y2ZGE5kIw130_assertion description "[TNF-A -863 AA genotype was associated with enhanced IBD susceptibility (odds ratio (OR), 4.82; 95% confidence interval (CI), 2.60-8.96), more so for UC (OR, 5.79; 95% CI, 2.99-11.21), Crohn's disease [CD] (OR, 3.13; 95% CI, 1.16-8.47).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP884827.RAaLAWI55TbwJ8nHGKhZzvA2-aG8VZjDlW43y2ZGE5kIw130_provenance.
- NP866560.RAy6SydFZlHdXIQXM4i2qlExMdO3ldLD5KbfQ1o-kvAes130_assertion description "[TNF-A -863 AA genotype was associated with enhanced IBD susceptibility (odds ratio (OR), 4.82; 95% confidence interval (CI), 2.60-8.96), more so for UC (OR, 5.79; 95% CI, 2.99-11.21), Crohn's disease [CD] (OR, 3.13; 95% CI, 1.16-8.47).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP866560.RAy6SydFZlHdXIQXM4i2qlExMdO3ldLD5KbfQ1o-kvAes130_provenance.
- assertion description "[TNF-A -863 AA genotype was associated with enhanced IBD susceptibility (odds ratio (OR), 4.82; 95% confidence interval (CI), 2.60-8.96), more so for UC (OR, 5.79; 95% CI, 2.99-11.21), Crohn's disease [CD] (OR, 3.13; 95% CI, 1.16-8.47).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP743656.RAqz2cjJf3xFCARFTkwJdXix51bgdwGtM0XNOam1WQK7Q130_assertion description "[TNF-A -863 AA genotype was associated with enhanced IBD susceptibility (odds ratio (OR), 4.82; 95% confidence interval (CI), 2.60-8.96), more so for UC (OR, 5.79; 95% CI, 2.99-11.21), Crohn's disease [CD] (OR, 3.13; 95% CI, 1.16-8.47).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP743656.RAqz2cjJf3xFCARFTkwJdXix51bgdwGtM0XNOam1WQK7Q130_provenance.